Syndrome News and Research

RSS

Second part of the 2009 Food Safety Naughty and Nice list released

Food Safety News, the web-based newspaper that covers all things food safety, today released the second part of its 2009 Food Safety Naughty and Nice list. The web-based newspaper’s “Naughty” list was published yesterday and included food safety missteps, missed opportunities, and downright dirty deeds.

28 Dec 2009

Study suggests Fanconi Anemia and Bloom's Syndrome proteins may act in common DNA repair pathway

A new study establishes a molecular link that bridges two rare inherited disorders and explains why these diseases result in genetic instability. The research, published by Cell Press in the December 24th issue of the journal Molecular Cell, may lead to a better understanding of the complex mechanisms that enable cells to repair damaged DNA.

28 Dec 2009

Test tube experiments show slight changes in protein chemistry can eliminate Huntington's disease in mice

In Huntington's disease, a mutated protein in the body becomes toxic to brain cells. Recent studies have demonstrated that a small region adjacent to the mutated segment plays a major role in the toxicity. Two new studies supported by the National Institutes of Health show that very slight changes to this region can eliminate signs of Huntington's disease in mice.

28 Dec 2009

Findings may shed light on the origins of autism and attention deficit disorders

Like a spotlight that illuminates an otherwise dark scene, attention brings to mind specific details of our environment while shutting others out. A new study by researchers at the Salk Institute for Biological Studies shows that the superior colliculus, a brain structure that primarily had been known for its role in the control of eye and head movements, is crucial for moving the mind's spotlight.

28 Dec 2009

NHLBI grant for identifying genetic and epigenetic causes of human congenital heart disease

Researchers at Children's Hospital Boston and Brigham and Women's Hospital have received funding from the National Heart, Lung, and Blood Institute (NHLBI) to support their search for undiscovered gene defects that cause congenital heart disease. The $4.19 million, 6-year grant is part of the Pediatric Cardiac Genomics Consortium (PCGC), which seeks to identify genetic and epigenetic causes of human congenital heart disease, and relate genetic variants present in the congenital heart disease patient population to clinical outcomes.

23 Dec 2009

MSH6 mutation carriers at elevated risk for colorectal, endometrial and lynch syndrome cancers

People carrying the germ-line MSH6 mutation are at high risk by age 80 years for colorectal and endometrial cancers and any cancer associated with Lynch syndrome, according to a new study published online December 22 in the Journal of the National Cancer Institute.

23 Dec 2009

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).

23 Dec 2009

Riverside Medical Center launches new diabetes prevention program

Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.

23 Dec 2009

Back pain problems continue to rise in U.S.

The Bonati Spine Institute, the leader in minimally invasive laser spine surgery, reports the results of studies that Americans are increasingly reporting back pain and spending more on back pain, but cautions consumers to carefully research the experience and the surgical outcome results when choosing their spine team.

23 Dec 2009

Niacin may not be beneficial for type 2 diabetic patients

High-density lipoprotein (HDL), known as "good" cholesterol, isn't as protective for people with type 2 diabetes, according to research reported in Circulation: Journal of the American Heart Association.

22 Dec 2009

Former CDC head to lead Merck's vaccine division

The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.

22 Dec 2009

A properly managed metabolic detoxification program can benefit

“Detox” programs have been in the spotlight recently, with a bevy of Hollywood celebrities citing their “detox” programs as the secret to looking great on the red carpet. But, what exactly is detoxification? Is it merely the latest health and beauty fad, or is it a true health therapy? And can anyone besides the Hollywood elite benefit from it?

22 Dec 2009

Relatives of men with cryptorchidism or hypospadias not at risk of developing testicular germ cell cancer

Boys with the sexual birth defects known as hypospadias and cryptorchidism are at risk for developing testicular germ cell cancer, but their relatives are not, according to a new study published online December 21 in the Journal of the National Cancer Institute.

22 Dec 2009

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Emisphere Technologies, Inc. today announced a meta-analysis published in the December 2009 edition of Rheumatology Reports examining independent evidence of the analgesic action of the hormone calcitonin. This publication restates the potential of calcitonin in filling a significant unmet need for alternative treatments for persistent musculoskeletal pain.

22 Dec 2009

Urigen Pharmaceuticals and Oceana Therapeutics jointly prepare for meeting with FDA on URG101

Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the Company and Oceana Therapeutics have agreed to jointly prepare for a meeting with the U.S. Food & Drug Administration regarding the continued development of URG101.

22 Dec 2009

Omega-3 fatty acids lower AMD and chronic kidney disease, improve heart health

Start 2010 right: consume more seafood omega-3 fatty acids. Improvements or lower risks in age-related macular degeneration (AMD), chronic kidney disease and heart health have been reported in people with higher intakes of fatty fish or the omega-3s they contain.

22 Dec 2009

Discovery suggests how toxin-filtering cells go awry

Researchers from Children's Hospital Boston and Brigham and Women's Hospital have identified an important genetic cause of a devastating kidney disease that is the second leading cause of kidney failure in children, according to The NephCure Foundation.

22 Dec 2009

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Neurocrine Biosciences, Inc. today announced their highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor, NBI-98854, will be advanced in clinical development.

21 Dec 2009

Nutricia North America improves its packaging with BPA-free lining for all powdered products

Nutricia North America, a manufacturer of medical foods and specialized infant formulas such as Neocate®, announced today that it has begun packaging its powdered medical foods and specialized infant formulas in cans with BPA-free lining.

18 Dec 2009

Immuno Laboratories and TRPN sign agreement to reduce chronic illness

Immuno Laboratories, a leading provider of food and environmental allergy testing services, announced an agreement with Three Rivers Provider Network (TRPN), the largest and fastest growing proprietary Preferred Provider Organization (PPO) network in the United States.

18 Dec 2009

Syndrome News and Research

Second part of the 2009 Food Safety Naughty and Nice list released

Study suggests Fanconi Anemia and Bloom's Syndrome proteins may act in common DNA repair pathway

Test tube experiments show slight changes in protein chemistry can eliminate Huntington's disease in mice

Findings may shed light on the origins of autism and attention deficit disorders

NHLBI grant for identifying genetic and epigenetic causes of human congenital heart disease

MSH6 mutation carriers at elevated risk for colorectal, endometrial and lynch syndrome cancers

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

Riverside Medical Center launches new diabetes prevention program

Back pain problems continue to rise in U.S.

Niacin may not be beneficial for type 2 diabetic patients

Former CDC head to lead Merck's vaccine division

A properly managed metabolic detoxification program can benefit

Relatives of men with cryptorchidism or hypospadias not at risk of developing testicular germ cell cancer

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Urigen Pharmaceuticals and Oceana Therapeutics jointly prepare for meeting with FDA on URG101

Omega-3 fatty acids lower AMD and chronic kidney disease, improve heart health

Discovery suggests how toxin-filtering cells go awry

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Nutricia North America improves its packaging with BPA-free lining for all powdered products

Immuno Laboratories and TRPN sign agreement to reduce chronic illness

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News